Cencora
COR
Performance
About Cencora
Cencora is a global healthcare logistics and pharmaceutical distribution company formed from AmerisourceBergen. It combines core drug distribution with innovative capabilities to help partners across the healthcare spectrum get medications to patients who need them, worldwide. The company emphasizes end-to-end capabilities including logistics and warehousing, drug research and clinical development support, commercialization support, and patient access and adherence solutions, serving pharma manufacturers, providers, health systems, and government in more than 50 countries.
Recent News
Q&A: How 3PLs Are Navigating the Latest Pharma Trends
Cencora Lifts FY26 Earnings Outlook and Adds up to $2 Billion to Share Buyback
Unlocking More Value From Mature Drug Products Through Strategic Outsourcing
Cencora Lifts FY26 Earnings Outlook and Adds up to $2 Bn to Share Buyback
Participating Faculty: Clinical Management and Economic Drivers of Heart Failure With Preserved or Mildly Reduced Ejection Fraction
Gaining Supplier Trust, Transparency, and Cross-Functional Collaboration During a Period of Volatility
How Pharma Supply Chains Can Brace for FDA’s 12-Digit NDC Standard
CSV: The X Factor for Being Breach Ready in Pharma
Understanding Supply Chain Constraints to Enable Growth for Cell & Gene Therapies
Factors Contributing to the Growth of Radiopharmaceuticals: Q&A with Andrea Zobel and Marco Hogenboom
Wilfong Joins Navista as Chief Medical Officer: “We Really Want to Partner With Practices”
Q&A: How RWE Is Reshaping Specialty Pharma Market Access